1.Production of human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus transformation.
Seung Min YOO ; Jeong Je CHO ; Soon Tae HO ; Youn Mun HA
Korean Journal of Immunology 1993;15(2):139-146
No abstract available.
Antibodies, Monoclonal*
;
Herpesvirus 4, Human*
;
Humans*
;
Tetanus Toxoid*
;
Tetanus*
2.S Antigen Specific Rat Helper T Cell Line Induced Experimental Autoimmune Uveoretinitis.
Youn Mun HA ; Soon Tae HO ; Jeong Je CHO ; Seung Min YOO
Korean Journal of Immunology 1997;19(2):181-188
No abstract available.
Adaptive Immunity
;
Animals
;
Cell Line*
;
Rats*
3.Dermoscopic Findings in Onychomycosis.
Korean Journal of Medical Mycology 2017;22(1):50-51
No abstract available.
Dermoscopy
;
Mycoses
;
Onychomycosis*
4.Production of monoclonal antibody to Epstein-Barr virus antigen.
Jeong Je CHO ; Soon Tae HO ; Seung Min YOO ; Youn Mun HA
Korean Journal of Immunology 1992;14(1):117-131
No abstract available.
Herpesvirus 4, Human*
5.Onychopapilloma Presenting as Erythronychia and Leukonychia: Dermoscopic Features of Two Cases in Korea.
Minsoo KIM ; Gwanghyun JO ; Cheol LEE ; Je Ho MUN
Annals of Dermatology 2018;30(6):742-744
No abstract available.
Korea*
7.Pigmented Onychomatricoma Showing a Longitudinal Melanonychia: A Case Report and Brief Review of Literature.
Sung Cheol JUNG ; Tae Min LEE ; Minsoo KIM ; Gwanghyun JO ; Je Ho MUN
Annals of Dermatology 2018;30(5):637-639
No abstract available.
Nail Diseases
;
Nails, Malformed
;
Melanoma
;
Skin Neoplasms
10.Effect of Human Immunoglobulin G in Pneumoconiotic Patients with Pneumonia.
Je Hyuk MUN ; Jin Suk CHUNG ; Kyoung Ah KIM ; Young LIM ; Ho Woo NAM ; Joong Soo HAN
Korean Journal of Occupational and Environmental Medicine 2002;14(2):134-142
OBJECTIVES: It is well known that pneumoconiotic patients experience impairments of macrophage function, as well as poor penetration of drugs into the fibrotic nodules and the immune system. Resultantly, pneumonia is frequently involved in pneumoconiotic patients and its treatment is not easy. Therefore, we conducted a clinical evaluation of immunoglobulin G which is known to be effective in severe infectious diseases. METHODS: We randomly selected 45 pneumoconiotic patients with pneumonia and classified them into 2 groups. The experimental group (IgG group) was scheduled to receive antibiotics and IgG (5 g I.V./day for 7 days). The control group was treated with antibiotics alone. Sputum gram stain (counts of WBCs and microorganisms), body temperature, arterial oxygen tension, and counts of peripheral venous blood leukocytes and band neutrophils were used as markers to assess the response effect therapy at time periods of 0, 2, 4, 6, and 8 days after completion of therapy. We compared the clinical scores between the two groups. RESULTS: The experimental IgG treated group was composed of 27 patients, and the control group comprised 18 patients. There was no statistical differences between two groups in terms of age, pneumoconiotic profusion, impairment degree of pulmonary function, or frequency of pathogen isolation in the sputum before medication. The experimental IgG treated group showed lower clinical scores as compared with the control group (p=0.083). CONCLUSIONS: These results suggest that IgG infusion with antibiotics will have an effect on pneumonia therapy in pneumoconiosis patients that are under 60 years and exhibit simple pneumoconiosis.
Anti-Bacterial Agents
;
Body Temperature
;
Communicable Diseases
;
Humans*
;
Immune System
;
Immunoglobulin G*
;
Immunoglobulins*
;
Leukocytes
;
Macrophages
;
Neutrophils
;
Oxygen
;
Pneumoconiosis
;
Pneumonia*
;
Sputum
Result Analysis
Print
Save
E-mail